Skip to content
The Nexus
HEALTHMay 31 · 15:43 UTCHACKER NEWSc-oreills

Daily pill can double survival time for deadliest cancer, trial shows

A daily pill called Daraxonrasib was found to double survival time for pancreatic cancer patients in a clinical trial, according to a study. The treatment shows significant improvement in outcomes for the deadliest form of cancer.

Nexus surfaces and summarizes. The full story lives at the source.

Mentioned
Daraxonrasibtopicpancreatic cancertopicclinical trialtopicThe Guardianorganization
Spot something wrong with this article?Report a problem →
Forward this
Related Signal

Adjacent reporting